OurCrowd Ltd., a Jerusalem-based crowdfunding investment platform comparable to AngelList, is raising a $100 million fund to finance early-stage companies focusing on artificial intelligence, deep-learning and robotics.
Read more on Bloomberg here.
![[DreaMed in Business Wire] DreaMed Receives FDA Clearance for its Type 2 Diabetes AI-based Clinical Decision Support System](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
[DreaMed in Business Wire] DreaMed Receives FDA Clearance for its Type 2 Diabetes AI-based Clinical Decision Support System
October 6, 2021
[OurCrowd in Bloomberg] Stifel CEO Says Wealth Management to Drive Growth This Year
February 12, 2020
